Christopher Baum (medic)

from Wikipedia, the free encyclopedia

Christopher Baum (born April 13, 1962 in Marburg , Germany ) is a German physician and molecular biologist. He is currently Vice President of the University of Lübeck and member of the board of the Schleswig-Holstein University Medical Center .

Education and functions

Christopher Baum studied human medicine in Essen , Freiburg and Hamburg . He obtained his doctorate in 1991. med. and worked the following year as a research assistant in the toxicology department at the University of Hamburg . From 1993 to 1999 he was team leader at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology , in Hamburg. In 1999 he completed his habilitation in molecular medicine at the University of Hamburg on gene therapy methods with the title "Chimerism and Evolution in the Organism". He then took up a C3 professorship for stem cell biology at the Hannover Medical School (MHH) in 2000 and was head of the Institute for Experimental Hematology from 2006 to 2013 as W3 professor. At the same time he was Associate Professor of Pediatrics at the Cincinnati Children's Hospital in the USA from 2002 to 2009 . From 2007 to 2013 he took on the role of Dean of Research at MHH and was elected President here in 2013. Baum has held the position of Vice President Medicine at the University of Lübeck since 2019 and is a member of the board of the Schleswig-Holstein University Medical Center (UKSH) . Here he is full-time responsible for research and teaching in medicine. Outside of the University of Lübeck, he is a member of the Presidium of the Medical Faculty Conference (MFT) and chairs the Research Group there.

Scientific focus

Scientifically, Christopher Baum was particularly concerned with gene therapy . He developed gene vectors for introducing genes into blood stem cells and uncovered the fundamentals of the so-called insertion mutagenesis in gene therapy, which can lead to blood cancer in patients treated with gene therapy . Building on this, he developed test procedures with which this side effect can be excluded before the genetically modified blood stem cells are transferred.

Awards

For his scientific work, Baum received the Ursula M. Handel Animal Welfare Prize from the German Research Foundation (DFG) and the Luise & Horst Köhler Prize for research on rare diseases.

Individual evidence

  1. ^ Vice-President Medicine: University of Lübeck. Retrieved August 3, 2020 .
  2. ↑ Christopher Baum becomes MHH President | Nds. Ministry of Science and Culture. Retrieved August 3, 2020 .
  3. ↑ Christopher Baum becomes MHH President | Nds. Ministry of Science and Culture. Retrieved August 4, 2020 .
  4. ↑ Presidium | Medical Faculty Day. Retrieved August 4, 2020 .
  5. ↑ DFG - GEPRIS - Professor Dr. Christopher Baum. Retrieved August 4, 2020 .
  6. ^ Vice-President Medicine: University of Lübeck. Retrieved August 4, 2020 .
personal data
SURNAME Baum, Christopher
BRIEF DESCRIPTION German physician and university professor
DATE OF BIRTH April 13, 1962
PLACE OF BIRTH Marburg